Jarrard DF - Search Results

1

Epigenetic field alterations in non-tumor prostate tissues detect prostate cancer in urine.

Khemees TA, Yang B, Schultz A, Allen GO, Gawdzik J, Nihal A, Richards KA, Abel EJ, Jarrard DF. Khemees TA, et al. Among authors: jarrard df. Am J Clin Exp Urol. 2021 Dec 15;9(6):479-488. eCollection 2021. Am J Clin Exp Urol. 2021. PMID: 34993267 Free PMC article.

2

The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.

Dobosy JR, Roberts JL, Fu VX, Jarrard DF. Dobosy JR, et al. Among authors: jarrard df. J Urol. 2007 Mar;177(3):822-31. doi: 10.1016/j.juro.2006.10.063. J Urol. 2007. PMID: 17296351 Review.

3

Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.

Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF. Bhusari S, et al. Among authors: jarrard df. Prostate. 2011 Nov;71(15):1621-30. doi: 10.1002/pros.21379. Epub 2011 Mar 22. Prostate. 2011. PMID: 21432864 Free PMC article.

4

Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence.

Truong M, Yang B, Wagner J, Kobayashi Y, Rajamanickam V, Brooks J, Jarrard DF. Truong M, et al. Among authors: jarrard df. Br J Cancer. 2012 Jun 26;107(1):100-7. doi: 10.1038/bjc.2012.216. Epub 2012 May 17. Br J Cancer. 2012. PMID: 22596233 Free PMC article.

5

Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo.

Ewald JA, Desotelle JA, Church DR, Yang B, Huang W, Laurila TA, Jarrard DF. Ewald JA, et al. Among authors: jarrard df. Prostate. 2013 Mar;73(4):337-45. doi: 10.1002/pros.22571. Epub 2012 Aug 21. Prostate. 2013. PMID: 22911222 Free PMC article.

6

Toward the detection of prostate cancer in urine: a critical analysis.

Truong M, Yang B, Jarrard DF. Truong M, et al. Among authors: jarrard df. J Urol. 2013 Feb;189(2):422-9. doi: 10.1016/j.juro.2012.04.143. Epub 2012 Sep 24. J Urol. 2013. PMID: 23017522 Free PMC article. Review.

7

Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.

Truong M, Yang B, Livermore A, Wagner J, Weeratunga P, Huang W, Dhir R, Nelson J, Lin DW, Jarrard DF. Truong M, et al. Among authors: jarrard df. J Urol. 2013 Jun;189(6):2335-41. doi: 10.1016/j.juro.2012.11.074. Epub 2012 Nov 15. J Urol. 2013. PMID: 23159584 Free PMC article.

8

CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer.

Desotelle J, Truong M, Ewald J, Weeratunga P, Yang B, Huang W, Jarrard D. Desotelle J, et al. J Urol. 2013 Jan;189(1):329-35. doi: 10.1016/j.juro.2012.08.188. Epub 2012 Nov 20. J Urol. 2013. PMID: 23174249 Free PMC article.

9

Analysis of promoter non-CG methylation in prostate cancer.

Truong M, Yang B, Wagner J, Desotelle J, Jarrard DF. Truong M, et al. Among authors: jarrard df. Epigenomics. 2013 Feb;5(1):65-71. doi: 10.2217/epi.12.67. Epigenomics. 2013. PMID: 23414321 Free PMC article.

10

Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer.

Yang B, Bhusari S, Kueck J, Weeratunga P, Wagner J, Leverson G, Huang W, Jarrard DF. Yang B, et al. Among authors: jarrard df. Neoplasia. 2013 Apr;15(4):399-408. doi: 10.1593/neo.13280. Neoplasia. 2013. PMID: 23555185 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters